Dextromethorphan Hbr/Quinidine
Brand name: Nuedexta
Rank #222 of 500 drugs by total cost
$60.7M
Total Cost
60,863
Total Claims
$60.7M
Total Cost
2,132
Prescribers
$997
Cost per Claim
984
Beneficiaries
62,350
30-Day Fills
$28K
Avg Cost/Provider
29
Avg Claims/Provider
About Dextromethorphan Hbr/Quinidine
Dextromethorphan Hbr/Quinidine (sold as Nuedexta) was prescribed 60,863 times by 2,132 Medicare Part D providers in 2023, costing the program $60.7M. At $997 per claim, this is a high-cost medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 219 | Furosemide (Furosemide) | $62.3M | 9,788,207 |
| 220 | Buprenorphine (Buprenorphine) | $61.1M | 156,598 |
| 221 | Ferric Citrate (Auryxia) | $60.7M | 32,798 |
| 222 | Dextromethorphan Hbr/Quinidine (Nuedexta) | $60.7M | 60,863 |
| 223 | Interferon Beta-1a/Albumin (Rebif) | $60.7M | 5,917 |
| 224 | Sodium Zirconium Cyclosilicate (Lokelma) | $60.2M | 77,902 |
| 225 | Golimumab (Simponi Aria) | $59.9M | 8,718 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology